Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | ATM | Q13315 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | CYP4F2 | P78329 | 2/20 | 0.40 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | PKM | P14618 | 1/20 | 0.36 |
| ▸ | CES2 | O00748 | 1/20 | 0.33 |
| ▸ | PPARG | P37231 | 1/20 | 0.32 |
| ▸ | PPARA | Q07869 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | FAAH | O00519 | 2/20 | 0.31 |
| ▸ | SMPD1 | P17405 | 1/20 | 0.31 |
| ▸ | NAAA | Q02083 | 1/20 | 0.31 |
| ▸ | DGKA | P23743 | 1/20 | 0.31 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL739576 | 0.96 | MEN1 (0.46) | MEN1KMT2AMAPTATML3MBTL1 | |
| SCHEMBL821391 | 0.91 | MEN1 (0.48) | MEN1KMT2AMAPTATML3MBTL1 | |
| Acetic Acid SCHEMBL560522 | 0.87 | MEN1 (0.48) | MEN1KMT2AMAPTATML3MBTL1 | |
| Acetic Acid SCHEMBL3191369 | 0.87 | MEN1 (0.48) | MEN1KMT2AMAPTATML3MBTL1 | |
| Acetic Acid SCHEMBL168910 | 0.87 | MEN1 (0.48) | MEN1KMT2AMAPTATML3MBTL1 | |
| Acetic Acid SCHEMBL18104018 | 0.87 | MEN1 (0.48) | MEN1KMT2AMAPTATML3MBTL1 | |
| Acetic Acid SCHEMBL7220949 | 0.87 | MEN1 (0.48) | MEN1KMT2AMAPTATML3MBTL1 | |
| Acetic Acid SCHEMBL18104054 | 0.86 | MEN1 (0.47) | MEN1KMT2AMAPTATML3MBTL1 | |
| Acetic Acid SCHEMBL5227791 | 0.86 | MEN1 (0.47) | MEN1KMT2AMAPTATML3MBTL1 | |
| SCHEMBL8673442 | 0.83 | MEN1 (0.49) | MEN1KMT2AMAPTATML3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230389408-A1 | METAL COMPLEX AND USE THEREOF | SICHUAN AG-RAY NEW MATERIALS CO., LTD (CN) | 2023-11-30 | — | — | US | disclosed |
| CN-114426563-B | Metal complex and application thereof | 四川阿格瑞新材料有限公司 | 2023-11-28 | — | — | CN | disclosed |
| CN-114426563-A | Metal complex and application thereof | 四川阿格瑞新材料有限公司 | 2022-05-03 | — | — | CN | disclosed |
| US-10710948-B2 | Processes for preparing (R)-1-(5-chloro-[1,1″-biphenyl] -2-yl)-2,2,2-trifluoroethanol and 1-(5-chloro-[1,1″-biphenyl]-2-yl)-2,2,2-trifluoroethanone | ROIVANT SCIENCES GMBH (CH) | 2020-07-14 | — | — | US | disclosed |
| CN-106146567-B | Organometallic compound and organic electroluminescent device comprising the same | 财团法人工业技术研究院 | 2019-10-01 | — | — | CN | disclosed |
| EP-2555273-B1 | ORGANIC ELECTRIC-FIELD LIGHT-EMITTING DEVICE MATERIAL, ORGANIC ELECTRIC-FIELD LIGHT-EMITTING DEVICE FORMED OF SAME, AND METHOD FOR MANUFACTURING ORGANIC ELECTRIC-FIELD LIGHT-EMITTING DEVICE | UDC IRELAND LTD (IE) | 2017-09-27 | — | — | EP | disclosed |
| US-20170204041-A1 | PROCESSES FOR PREPARING (R)-1-(5-CHLORO-[1,1`-BIPHENYL]-2-YL)-2,2,2-TRIFLUOROETHANOL AND 1-(5-CHLORO-[1,1`-BIPHENYL]-2-YL)-2,2,2-TRIFLUOROETHANONE | ROIVANT SCIENCES GMBH (CH) | 2017-07-20 | — | — | US | disclosed |
| CN-106946941-A | Organometallic complex and organic light emitting diode including the same | 财团法人工业技术研究院 | 2017-07-14 | — | — | CN | disclosed |
| US-9611201-B2 | Processes for preparing (R)-1-(5-chloro-[1,1′-biphenyl]-2-yl)-2,2,2-trifluoroethanol and 1-(5-chloro-[1,1′-biphenyl]-2-yl)-2,2,2-trifluoroethanone | KAROS PHARMACEUTICALS, INC. (US) | 2017-04-04 | — | — | US | disclosed |
| US-9601705-B2 | Material for organic electroluminescence element and organic electroluminescence element using the same, and method for manufacturing organic electroluminescence element | UDC IRELAND LIMITED (IE) | 2017-03-21 | — | — | US | disclosed |
| US-20030092695-A1 | Metal salts of 3-methyl-chromane or thiochromane derivatives | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2003-05-15 | — | — | US | disclosed |
| US-6552068-B1 | Having anti-estrogenic activity; for use in therapy | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2003-04-22 | — | — | US | disclosed |
| US-6552069-B1 | Having anti-estrogenic activity; for use in therapy | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2003-04-22 | — | — | US | disclosed |
| EP-1240155-A4 | METAL SALTS OF 3-METHYL-CHROMANE OR THIOCHROMANE DERIVATIVES | CHUGAI PHARMACEUTICAL CO LTD (JP) | 2003-04-16 | — | — | EP | disclosed |
| EP-1241167-A1 | 3-ETHYL-, 3-PROPYL- OR 3-BUTYL-CHROMAN AND -THIOCHROMAN DERIVATIVES | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2002-09-18 | — | — | EP | disclosed |
| EP-1241166-A1 | 3-METHYL-CHROMAN AND -THIOCHROMAN DERIVATIVES | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2002-09-18 | — | — | EP | disclosed |
| EP-1240155-A1 | METAL SALTS OF 3-METHYL-CHROMANE OR THIOCHROMANE DERIVATIVES | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2002-09-18 | — | — | EP | disclosed |
| US-6369110-B1 | PROPHYLACTIC AGENT FOR DISEASES CAUSED BY THE ACCELERATION OF THE SODIUM/PROTON EXCHANGE TRANSPORT SYSTEM | SUMITOMO PHARMACEUTICALS COMPANY (JP) | 2002-04-09 | — | — | US | disclosed |
| WO-2001042236-A1 | METAL SALTS OF 3-METHYL-CHROMANE OR THIOCHROMANE DERIVATIVES | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2001-06-14 | — | — | WO | disclosed |
| EP-1083166-A1 | NOVEL SUBSTITUTED GUANIDINE DERIVATIVES AND PROCESS FOR PRODUCING THE SAME | SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) | 2001-03-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170204041-A1 | PROCESSES FOR PREPARING (R)-1-(5-CHLORO-[1,1`-BIPHENYL]-2-YL)-2,2,2-TRIFLUOROETHANOL AND 1-(5-CHLORO-[1,1`-BIPHENYL]-2-YL)-2,2,2-TRIFLUOROETHANONE | TPH1, TPH2, HTR1A | MEN1 457/4885KMT2A 1144/4885MAPT 4603/4885 |
| US-20230389408-A1 | METAL COMPLEX AND USE THEREOF | CYBA, AP1M1, AP3M1 | MEN1 623/4885KMT2A 3897/4885MAPT 860/4885 |
| US-10710948-B2 | Processes for preparing (R)-1-(5-chloro-[1,1″-biphenyl] -2-yl)-2,2,2-trifluoroethanol and 1-(5-chloro-[1,1″-biphenyl]-2-yl)-2,2,2-trifluoroethanone | TPH1, TPH2, HTR1A | MEN1 465/4885KMT2A 1201/4885MAPT 4622/4885 |
| US-20030092695-A1 | Metal salts of 3-methyl-chromane or thiochromane derivatives | NR5A1, SHBG, ESR1 | MEN1 700/4885KMT2A 728/4885MAPT 1736/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.